InsiderTrades

Form 4 for WGS GeneDx Holdings Corp.

Accepted 2022-04-27 00:00:00 ET · period of report 2022-04-25 · accession 0001209191-22-025889 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-04-27 2022-04-25 WGS Clark Daniel Emmett GC, Sec M - OptEx — +3,940 310.8K +1% —
D 2022-04-27 2022-04-25 WGS Clark Daniel Emmett GC, Sec M - OptEx $0.00 -3,940 51.2K -7% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2022-04-25 M A 3,940 — 310,759 D — — (F1) Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
2 Derivative Restricted Stock Unit 2022-04-25 M D 3,940 $0.00 51,229 D — · — to — 3,940 Class A Common Stock (F1) Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F2) 6.25% vest in quarterly installments over the four-year period commencing on July 25, 2021 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.